Telix PharmaceuticalsTLX
13F holders, Q1 2026 (March 31)39holders −1
11new positions
11sold out
$9.53avg. 13F price*
At the end of Q1 2026, 39 institutions reported holding Telix Pharmaceuticals Ltd. (TLX) in their 13F filings, down 1 from Q4 2025. 11 opened new positions and 11 sold out. The largest holders were FMR LLC ($5.4M), Portolan Capital Management, LLC ($5.2M) and Lazard Asset Management LLC ($2.8M).
- Company
- Telix Pharmaceuticals Ltd.
- CUSIP
- 87961M105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $8.4M |
| Exits | 11 | $1.5M |
All 13F filers, Q4 2025 → Q1 2026: 1,680,370 shares bought and 231,767 shares sold, net +1,448,603 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 39 holders
| FMR LLC | 0.00% | Add +357.0% | 564,757 | $5.4M |
| Portolan Capital Management, LLC | 0.28% | New | 541,267 | $5.2M |
| Lazard Asset Management LLC | 0.00% | Add +15.7% | 289,917 | $2.8M |
| Portland Investment Counsel Inc. | 0.82% | No change | 266,200 | $2.5M |
| Private Advisor Group, LLC | 0.01% | Add +276.3% | 174,415 | $1.7M |
| Integrated Wealth Concepts LLC | 0.01% | New | 164,397 | $1.6M |
| Raiffeisen Bank International AG | 0.02% | New | 130,000 | $1.2M |
| Morgan Stanley | 0.00% | Add +559.6% | 116,440 | $1.1M |
| JPMorgan Chase & Co. | 0.00% | Reduce -22.9% | 57,348 | $514K |
| Mariner, LLC | 0.00% | Add +18.8% | 43,446 | $415K |
| Schonfeld Strategic Advisors LLC | 0.00% | New | 34,873 | $334K |
| Vanguard Personalized Indexing Management, LLC | 0.00% | Add +83.3% | 33,253 | $318K |
| UBS Group AG | 0.00% | Add +1544.6% | 32,300 | $309K |
| XTX Topco Ltd | 0.00% | Add +120.0% | 26,007 | $249K |
| IHT Wealth Management, LLC | 0.01% | Reduce -1.0% | 25,035 | $240K |
| Vident Advisory, LLC | 0.00% | Reduce -38.9% | 16,653 | $159K |
| XY Capital Ltd | 0.13% | New | 12,552 | $120K |
| BNP Paribas Financial Markets | 0.00% | Add +700.0% | 12,000 | $115K |
| Bank of America Corp. | 0.00% | Add +523.8% | 10,031 | $96K |
| Rhumbline Advisers | 0.00% | Reduce -8.9% | 9,823 | $94K |
| NewEdge Advisors, LLC | 0.00% | No change | 1,920 | $18K |
| EverSource Wealth Advisors, LLC | 0.00% | Add +104.0% | 1,832 | $18K |
| Cwm, LLC | 0.00% | New | 1,425 | $14K |
| Arax Advisory Partners | 0.00% | Reduce -88.5% | 125 | $10K |
| Larson Financial Group LLC | 0.00% | New | 899 | $9K |
| Osaic Holdings, Inc. | 0.00% | Add +140.8% | 756 | $7K |
| Blue Trust, Inc. | 0.00% | Reduce -76.0% | 742 | $7K |
| Aspect Partners, LLC | 0.00% | Add +8.0% | 380 | $4K |
| BlackRock, Inc. | 0.00% | Add +300.0% | 352 | $3K |
| Basecamp Wealth Advisors LLC | 0.00% | No change | 276 | $3K |
| Assetmark, Inc. | 0.00% | Add +240.0% | 153 | $1K |
| CVA Family Office, LLC | 0.00% | New | 127 | $1K |
| Bell Investment Advisors, Inc | 0.00% | New | 70 | $670 |
| Nisa Investment Advisors, LLC | 0.00% | New | 65 | $622 |
| MV Capital Management, Inc. | 0.00% | Add +454.6% | 61 | $584 |
| Smartleaf Asset Management LLC | 0.00% | Reduce -48.6% | 37 | $332 |
| Transamerica Financial Advisors, LLC | 0.00% | Add +12.0% | 28 | $267 |
| Farther Finance Advisors, LLC | 0.00% | No change | 9 | $83 |
| Parallel Advisors, LLC | 0.00% | Reduce -91.7% | 1 | $13 |
"% of holder's portfolio" is TLX's weight in each manager's 13F, not the share of Telix Pharmaceuticals Ltd. the manager owns.